Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Learn the long-term average annual return for index funds and how it informs portfolio construction, diversification, and risk management.
27,739 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
A June selloff tested leverage in Bitcoin-backed corporate debt, but the market has steadied. Dividend payments persi...
here thursday’s wall street mood shifts as fresh analyst notes touch on Astera Labs, Block, Digital Realty and others...
Two early leaders in the electric air taxi race collide with a policy signal that could tilt the field. This analysis...
3D Systems' Q1 2026 update sheds light on demand, margins, and cash flow across its printing systems, materials, and ...
Oracle's backlog surge and accelerating AI infrastructure growth are fueling a heated debate on whether the stock is ...
Arm Holdings trades around $347 as investors weigh AI-driven demand and data-center opportunities. Analysts see a pat...
This article breaks down a thoughtful framework for predicting the path of prediction: this tesla stock after Tesla's...
QuantumScape's solid-state battery efforts could redefine EV charging. This guide digs into what might drive QS stock...
Disney names Josh D’Amaro as CEO, effective March 18, 2026, ending a long succession saga. The new leader brings a un...
AXIA Energia completes its transition to 100% renewable power after divesting coal, delivering robust cash flow and e...
Bitcoin slumped sharply while major altcoins fell, erasing about $150 billion from crypto markets and stirring a fres...